浏览全部资源
扫码关注微信
1.甘肃中医药大学,兰州 730011
2.甘肃省人民医院,兰州 730000
毛海燕,博士,从事妇科血瘀证的临床与实验研究,E-mail:maohaiyan2040@163.com
武权生,硕士,教授,从事妇科血瘀证的临床与实验研究,E-mail:1364193682@qq.com; *
张小花,硕士,副教授,从事中医妇科教学、临床、科研工作,E-mail:283005688@qq.com
纸质出版日期:2022-06-20,
网络出版日期:2022-03-25,
收稿日期:2021-09-16,
扫 描 看 全 文
毛海燕,陈元欢,武权生等.加味少腹逐瘀汤对子宫内膜异位症寒凝血瘀证盆腔疼痛神经血管生成的影响[J].中国实验方剂学杂志,2022,28(12):141-147.
MAO Hai-yan,CHEN Yuan-huan,WU Quan-sheng,et al.Effect of Modified Shaofu Zhuyutang on Neural Angiogenesis and Pelvic Pain of Endometriosis with Syndrome of Cold Congeal and Blood Stasis[J].Chinese Journal of Experimental Traditional Medical Formulae,2022,28(12):141-147.
毛海燕,陈元欢,武权生等.加味少腹逐瘀汤对子宫内膜异位症寒凝血瘀证盆腔疼痛神经血管生成的影响[J].中国实验方剂学杂志,2022,28(12):141-147. DOI: 10.13422/j.cnki.syfjx.20221295.
MAO Hai-yan,CHEN Yuan-huan,WU Quan-sheng,et al.Effect of Modified Shaofu Zhuyutang on Neural Angiogenesis and Pelvic Pain of Endometriosis with Syndrome of Cold Congeal and Blood Stasis[J].Chinese Journal of Experimental Traditional Medical Formulae,2022,28(12):141-147. DOI: 10.13422/j.cnki.syfjx.20221295.
目的
2
评价加味少腹逐瘀汤治疗子宫内膜异位症寒凝血瘀证盆腔疼痛的临床疗效及对神经血管生成的影响。
方法
2
将110例符合标准的患者采用随机数字表法分为对照组(54例)和观察组(56例)。对照组口服艾附暖宫丸,6 g/次,2次/d;观察组口服加味少腹逐瘀汤,1剂/d。两组均连续治疗3个月经周期。治疗前后进行痛经、其他盆腔疼痛症状及盆腔疼痛体征评分;寒凝血瘀证和子宫内膜异位症患者生存质量量表(EHP-5)评分;检测治疗前后外周血神经生长因子(NGF)、P物质(SP)、降钙素基因相关肽(CGRP)、脑源性神经营养因子(BDNF)、血管内皮生长因子可溶性受体-1(sFlt-1)、血管内皮生长因子(VEGF)、基质金属蛋白酶-9(MMP-9)和胰岛素生长因子-1(IGF-1)水平;检测治疗前后前列腺素E
2
(PGE
2
)、环氧化酶2(COX-2)、肿瘤坏死因子-
α
(TNF-
α
)、白细胞介素-6(IL-6)等炎症因子水平。记录止痛药物使用量和复发情况。
结果
2
观察组痛经、其他盆腔疼痛症状(非经期盆腔痛、性交痛、肛门坠痛、排便痛等)和盆腔疼痛体征(盆腔压痛、骶韧带触痛结节)评分均低于对照组(
P
<
0.01);观察组患者痛经、盆腔压痛、骶韧带触痛结节的消失率分别为67.35%(33/49)、73.33%(33/45)、77.27%(34/44),均分别高于对照组的45.83%(22/48)、48.84%(21/43)和52.27%(23/44),差异有统计学意义(
χ
2
=4.571,
χ
2
=5.565,
χ
2
=6.026,
P
<
0.05);观察组EHP-5和寒凝血瘀证评分低于对照组(
P
<
0.01);观察组VEGF、MMP-9、IGF-1、NGF、SP、CGRP和BDNF水平低于对照组(
P
<
0.01),sFlt-1水平高于对照组(
P
<
0.01);观察组PGE
2
、COX-2、TNF-α和IL-6水平低于对照组(
P
<
0.01);观察组总有效率为92.45%(49/53),高于对照组的76.00%(38/50)(
χ
2
=5.307,
P
<
0.05);进行6个月的随访,观察组复发率为30.61%(15/49),低于对照组的52.63%(20/38)(
χ
2
=4.315,
P
<
0.05);对照组平均每个月经期服用布洛芬缓释胶囊高于观察组(
P
<
0.01)。
结论
2
加味少腹逐瘀汤治疗子宫内膜异位症盆腔疼痛寒凝血瘀证患者可调节神经血管生成机制,减轻疼痛,促进相关疼痛消失,提高了生活质量,临床疗效优于艾附暖宫丸,且复发率低。
Objective
2
To evaluate the clinical curative effect of modified Shaofu Zhuyutang on pelvic pain of endometriosis (EMT) with syndrome of cold congeal and blood stasis and the influence on neural angiogenesis.
Method
2
A total of 110 cases were divided into a control group (54 cases) and an observation group (56 cases) by the random number table method. Patients in the control group took Aifu Nuangong pills with 6 g/time and 2 times/day. Patients in the observation group took modified Shaofu Zhuyutang with 1 dose/day. Course of treatment continued for 3 menstrual cycles. Dysmenorrhea, other symptoms and signs of pelvic pain, and the EMT health profile-5 (EHP-5) for patients with syndrome of cold congeal and blood stasis and EMT were scored before and after treatment. The levels of peripheral blood nerve growth factor (NGF), substance P (SP), calcitonin gene-related peptide (CGRP), brain-derived neurotrophic factor (BDNF), soluble Fms-like tyrosine kinase(sFlt-1), vascular endothelial growth factor (VEGF), matrix metalloproteinase-9 (MMP-9), and insulin growth factor-1 (IGF-1) were detected before and after treatment. The levels of prostaglandin E
2
(PGE
2
), cyclooxygenase-2 (COX-2), tumor necrosis factor-
α
(TNF-
α
), interleukin-6 (IL-6), and other inflammatory factors were detected before and after treatment. The pain medication usage and recurrence were recorded.
Result
2
The scores of dysmenorrhea, symptoms of pelvic pain symptoms (non-menstrual pelvic pain, dyspareunia, anal falling pain, and defecation pain, etc.), and signs of pelvic pain (pelvic tenderness and sacral ligament tender nodules) in the observation group were lower than those in the control group (
P
<
0.01). The disappearance rates of dysmenorrhea, pelvic tenderness, and sacral ligament tender nodules were 67.35% (33/49), 73.33% (33/45), and 77.27% (34/44) in the observation group, which were all higher than 45.83% (22/48), 48.84% (21/43), and 52.27% (23/44) in the control group. The difference was statistically significant (
χ
2
=4.571,
χ
2
=5.565,
χ
2
=6.026,
P
<
0.05). The scores of EHP-5 and syndrome of cold congeal and blood stasis in the observation group were lower than those in the control group (
P
<
0.01). The levels of VEGF, MMP-9, IGF-1, NGF, SP, CGRP, and BDNF in the observation group were lower than those in the control group (
P
<
0.01), while the level of sFlt-1 was higher than that in the control group (
P
<
0.01). The levels of PGE
2
, COX-2, TNF-α, and IL-6 in the observation group were lower than those in the control group (
P
<
0.01). The total effective rate of the observation group was 92.45% (49/53), which was higher than 76.00% (38/50) of the control group (
χ
2
=5.307,
P
<
0.05). After 6 months of follow-up, the recurrence rate in the observation group was 30.61% (15/49), which was lower than 52.63% (20/38) in the control group (
χ
2
=4.315,
P
<
0.05). The average of taking ibuprofen sustained-release capsules in the control group was higher than that in the observation group per menstrual period (
P
<
0.01).
Conclusion
2
Modified Shaofu Zhuyutang treated pelvic pain of EMT with syndrome of cold congeal and blood stasis by regulating the mechanism of neural angiogenesis, reducing pain, and promoting the disappearance of related pains, thus improving the quality of life. Shaofu Zhuyutang has a better clinical effect than Aifu Nuangong pills and has a low recurrence rate.
子宫内膜异位症盆腔疼痛寒凝血瘀证加味少腹逐瘀汤神经机制血管生成
endometriosispelvic painsyndrome of cold congeal and blood stasismodified Shaofu Zhuyutangneural mechanismangiogenesis
中国医师协会妇产科医师分会子宫内膜异位症专业委员会,中华医学会妇产科学分会子宫内膜异位症协作组.子宫内膜异位症长期管理中国专家共识[J].中华妇产科杂志,2018,53(12):836-841.
中国中西医结合学会妇产科专业委员会.子宫内膜异位症中西医结合诊治指南[J].中国中西医结合杂志,2019,39(10):1169-1176.
郎景和.对子宫内膜异位症认识的历史、现状与发展[J].中国实用妇科与产科杂志,2020,36(3):193-196.
樊琼,韦玉娜,尹玲,等.大黄庶虫虫丸治疗子宫内膜异位症盆腔疼痛气滞血瘀证的临床观察[J].中国实验方剂学杂志,2019,25(12):121-126.
崔良慧,杨佳.温针灸联合内异煎对寒凝血瘀型子宫内膜异位症痛经患者的临床疗效[J].中成药,2021,43(4):926-929.
崔楠,黄灿灿,折娅欢,等.温肾暖宫方联合西药治疗寒凝血瘀型子宫内膜异位症痛经的临床观察[J].中华中医药杂志,2019,34(10):4950-4953.
王玉梅,武权生,崔楠,等.温肾化瘀序贯疗法联合三伏隔姜灸治疗寒凝血瘀型子宫内膜异位症痛经的临床观察[J].时珍国医国药,2021,32(4):908-910.
梁莉,武权生,张小花,等.少腹逐瘀汤治疗寒凝血瘀型子宫内膜异位症痛经研究进展[J].时珍国医国药,2021,32(2):437-440.
陈元欢,张作良,武权生,等.基于网络药理学和分子对接探讨少腹逐瘀汤治疗EMT痛经的作用机制[J].中国中药杂志,2021,46(24):6484-6492.
郑玮琳,梁雪芳,许铮,等.子宫内膜异位症相关性疼痛与促神经血管生成机制中西医研究进展[J].中华中医药学刊,2018,36(9):2138-2142.
郑筱萸.中药新药临床研究指导原则(试行)[M].北京:中国医药科技出版社,1993:263-266.
武梅,刘德慧,俞超芹.子宫内膜异位症中医证候初探[J].辽宁中医杂志,2020,47(5):32-38.
MAY K,BECKER C M.Endometriosis and angiogenesis[J].Minerva Ginecol,2008,60(3):245-254.
FORSTER R,SARGINSON A,VELICHKOVA A,et al.Macrophage-derived insulin-like growth factor-1 is a key neurotrophic and nerve-sensitizing factor in pain associated with endometriosis[J].FASEB J,2019,33(10):11210-11222.
高扬,朱艳.子宫内膜异位症合并不孕患者血清中基质金属蛋白酶-9、基质金属蛋白酶抑制剂-1、血管内皮生长因子可溶性受体、胰岛素生长因子-1、单核细胞趋化蛋白-1表达水平及临床意义[J].陕西医学杂志,2020,49(4):462-465,501.
杨剑,孟鑫,李颖,等.NGF、TRPV1在子宫内膜异位症患者中的表达及与疼痛的关系[J].解放军医药杂志,2021,33(1):76-80.
LIU Y,QIN X,LU X,et al.Effects of inhibiting the PI3K/Akt/mTOR signaling pathway on the pain of sciatic endometriosis in a rat model[J].Can J Physiol Pharmacol,2019,97(10):963-970.
童邦菊,卢美松,邓锁,等.P物质在子宫内膜异位症中的表达及其意义[J].现代生物医学进展,2015,15(4):679-681,717.
李金铭,王琳.脑源性神经营养因子在子宫内膜异位症及其相关疼痛中的研究进展[J].国际妇产科学杂志,2021,48(3):281-285.
BLAIS M,LÉVESQUE P,BELLENFANT S,et al.Nerve growth factor, brain-derived neurotrophic factor, neurotrophin-3 and glial-derived neurotrophic factor enhance angiogenesis in a tissue-engineered in vitro model[J].Tissue Eng Part A,2013,19(15/16):1655-1664.
苏文良,马璐璐,张秀华,等.子宫内膜异位症相关疼痛机制研究进展[J].协和医学杂志,2020,11(4):439-442.
0
浏览量
10
下载量
3
CSCD
关联资源
相关文章
相关作者
相关机构